Of particular note is that calreticulin (CALR) was associated with both “metabolism of proteins” and “vesicle-mediated transport” pathways (Figure 4B) and was the only protein identified with a consistent direction of differential expression across SMA and ALS proteomic studies (Figure 2B). This evidence concerns the gene SMN1 and amyotrophic lateral sclerosis.